Advertisement

Topics

Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

19:00 EDT 23 Aug 2018 | Net Resources International

Harbour BioMed has signed a collaboration agreement with Kelun-Biotech Biopharmaceutical to develop and commercialise A167, an anti-PD-L1 antibody indicated for...
Read More...

The post Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology appeared first on Drug Development Technology.

Original Article: Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology

NEXT ARTICLE

More From BioPortfolio on "Deals this week: Harbour BioMed, Emergent BioSolutions, Sierra Oncology"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Mergers & Acquisitions
Commercial and market reports on mergers and acquisitions in the biotechnology, pharmaceutical, medical device and life-science industries. Mergers and acquisitions (abbreviated M&A;) is an aspect of corporate strategy, corporate finance and manageme...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...